Related Experiment Video
Updated: Jun 29, 2025
09:01
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
332
Chemotherapy and the Extra-Tumor Immune Microenvironment: EXTRA-TIME.
Tri Giang Phan1,2, Katherine N Weilbaecher3, Rebecca Aft4
1Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
Cancer Discovery
|April 4, 2024
Summary
Conventional cancer therapies focus on primary tumors. This study questions if these treatments inadvertently increase the risk of metastatic relapse, impacting long-term patient outcomes.
Area of Science:
- Oncology
- Cancer Metastasis Research
Background:
- Conventional cancer treatments primarily target the primary tumor site.
- The long-term consequences of these focused therapeutic strategies on metastatic progression are not fully understood.
Purpose of the Study:
- To investigate the potential link between conventional primary tumor-focused therapies and the subsequent risk of metastatic relapse.
- To evaluate if current treatment paradigms may inadvertently promote cancer spread.
Main Methods:
- This study involves a critical review of existing oncological treatment data and outcomes.
- Analysis of patient data to correlate primary tumor treatment modalities with metastatic recurrence rates.
Main Results:
- Preliminary findings suggest a potential correlation between certain conventional therapies and an elevated likelihood of metastatic relapse.
- Further research is needed to elucidate the mechanisms driving this observed association.
Conclusions:
- Conventional therapeutic strategies for primary tumors may carry an unintended cost: an increased risk of metastatic relapse.
- Re-evaluation of current treatment protocols is warranted to mitigate the risk of cancer dissemination.
Related Concept Videos
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:27Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:30Cancer Vaccines
363
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
363